Adamas Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ADMS and buy or sell other stocks, ETFs, and their options commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. 

CEO
Neil F. McFarlane
CEONeil F. McFarlane
Employees
Employees
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2000
Founded2000
Employees
Employees

ADMS Key Statistics

Market cap
376.37M
Market cap376.37M
Price-Earnings ratio
-4.85
Price-Earnings ratio-4.85
Dividend yield
Dividend yield
Average volume
964.73K
Average volume964.73K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$9.15
52 Week high$9.15
52 Week low
$4.02
52 Week low$4.02

Stock Snapshot

Adamas Pharmaceuticals(ADMS) stock is priced at $8.22, giving the company a market capitalization of 376.37M. It carries a P/E multiple of -4.85.

Adamas Pharmaceuticals(ADMS) stock opened on 2026-02-06 at —. The price climbed to — and dipped to —.

The Adamas Pharmaceuticals(ADMS)'s current trading volume is 0, compared to an average daily volume of 964.73K.

During the past year, Adamas Pharmaceuticals(ADMS) stock moved between $4.02 at its lowest and $9.15 at its peak.

During the past year, Adamas Pharmaceuticals(ADMS) stock moved between $4.02 at its lowest and $9.15 at its peak.

People also own

Based on the portfolios of people who own ADMS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.